Announcements Trials
Browse Landscape

Phase

Phase 2 92Phase 1 39Phase 1/2 31Phase 3 26Phase NA 4Phase 4 4Phase 2/3 4Phase EARLY_PHASE1 1

Status

Unknown 3Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 26Thoracic 6Genitourinary 6Lymphoid 4Head & Neck 3Gynecologic 2Sarcoma 1

Conditions

Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Immunoblastic Lymphadenopathy 1

Interventions

Cyclophosphamide 47Rituximab 34Exercise 25fludarabine phosphate 24Methotrexate 24Blood Specimen Collection 23Vincristine 21Cytarabine 21Radiotherapy 20Filgrastim 19Peripheral Blood Stem Cell Transplantation 18Whole-Body Irradiation 17Prednisone 16Melphalan 16Etoposide 16Cyclosporine 16Methods 15Dexamethasone 15Busulfan 15Antilymphocyte Serum 15fludarabine 14Doxorubicin 14Educational Status 13Mycophenolic Acid 12Magnetic Resonance Spectroscopy 11Early Intervention, Educational 11Therapeutics 10Surveys and Questionnaires 9Standard of Care 9Prednisolone 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Gemcitabine × Lymphoid × Clear all
NCT06211881 2024-01-18

Chi-GVM Regimen for the Treatment of R/R PTCL

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown
50 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT05821192 2023-04-20

Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.

The First Hospital of Jilin University

Phase NA Unknown
34 enrolled
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell

NCT02733458 2021-09-14

GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase NA Completed
52 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT04432402 2020-06-16

Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown
124 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡